202 related articles for article (PubMed ID: 17592742)
1. Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper(II). Synthesis, X-ray structure for copper(II)-isoxicam, -meloxicam and -cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)-piroxicam complex.
Cini R; Tamasi G; Defazio S; Hursthouse MB
J Inorg Biochem; 2007 Aug; 101(8):1140-52. PubMed ID: 17592742
[TBL] [Abstract][Full Text] [Related]
2. Release studies from smart hydrogels as carriers for piroxicam and copper(II)-oxicam complexes as anti-inflammatory and anti-cancer drugs. X-ray structures of new copper(II)-piroxicam and -isoxicam complex molecules.
Tamasi G; Serinelli F; Consumi M; Magnani A; Casolaro M; Cini R
J Inorg Biochem; 2008 Oct; 102(10):1862-73. PubMed ID: 18667239
[TBL] [Abstract][Full Text] [Related]
3. New platinum-oxicam complexes as anti-cancer drugs. Synthesis, characterization, release studies from smart hydrogels, evaluation of reactivity with selected proteins and cytotoxic activity in vitro.
Tamasi G; Casolaro M; Magnani A; Sega A; Chiasserini L; Messori L; Gabbiani C; Valiahdi SM; Jakupec MA; Keppler BK; Hursthouse MB; Cini R
J Inorg Biochem; 2010 Aug; 104(8):799-814. PubMed ID: 20447694
[TBL] [Abstract][Full Text] [Related]
4. Oxygen Radical Scavenger Activity, EPR, NMR, Molecular Mechanics and Extended-Hückel Molecular Orbital Investigation of the Bis(Piroxicam)Copper(II) Complex.
Cini R; Pogni R; Basosi R; Donati A; Rossi C; Sabadini L; Rollo L; Lorenzini S; Gelli R; Marcolongo R
Met Based Drugs; 1995; 2(1):43-56. PubMed ID: 18472745
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic studies of the binding of Cu(II) complexes of oxicam NSAIDs to alternating G-C and homopolymeric G-C sequences.
Chakraborty S; Bose M; Sarkar M
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Mar; 122():690-7. PubMed ID: 24345609
[TBL] [Abstract][Full Text] [Related]
6. Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone.
Roy S; Banerjee R; Sarkar M
J Inorg Biochem; 2006 Aug; 100(8):1320-31. PubMed ID: 16684565
[TBL] [Abstract][Full Text] [Related]
7. Anti-Inflammatory Oxicams as Multi-donor Ligand Systems: pH- and Solvent-Dependent Coordination Modes of Meloxicam and Piroxicam to Ru and Os.
Aman F; Hanif M; Kubanik M; Ashraf A; Söhnel T; Jamieson SM; Siddiqui WA; Hartinger CG
Chemistry; 2017 Apr; 23(20):4893-4902. PubMed ID: 28198061
[TBL] [Abstract][Full Text] [Related]
8. Copper(II) complexes with the non-steroidal anti-inflammatory drug tolfenamic acid: Structure and biological features.
Tarushi A; Perontsis S; Hatzidimitriou AG; Papadopoulos AN; Kessissoglou DP; Psomas G
J Inorg Biochem; 2015 Aug; 149():68-79. PubMed ID: 25824465
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic studies on the interaction of DNA with the copper complexes of NSAIDs lornoxicam and isoxicam.
Goswami S; Ray S; Sarkar M
Int J Biol Macromol; 2016 Dec; 93(Pt A):47-56. PubMed ID: 27554932
[TBL] [Abstract][Full Text] [Related]
10. [The binding of oxicam derivatives to human serum albumin].
Kinawi A; Siebler D
Arzneimittelforschung; 1988 Aug; 38(8):1089-92. PubMed ID: 3264167
[TBL] [Abstract][Full Text] [Related]
11. Binding of Cu(II) complexes of oxicam NSAIDs to alternating AT and homopolymeric AT sequences: differential response to variation in backbone structure.
Chakraborty S; Sehanobish E; Sarkar M
J Biol Inorg Chem; 2012 Mar; 17(3):475-87. PubMed ID: 22270943
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, crystal structure, and cytotoxic activity of novel cyclic systems in [1,2,4]thiadiazolo[2,3-a]pyridine benzamide derivatives and their copper(II) complexes.
Adhami F; Safavi M; Ehsani M; Ardestani SK; Emmerling F; Simyari F
Dalton Trans; 2014 Jun; 43(21):7945-57. PubMed ID: 24715093
[TBL] [Abstract][Full Text] [Related]
13. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
Porchia M; Benetollo F; Refosco F; Tisato F; Marzano C; Gandin V
J Inorg Biochem; 2009 Dec; 103(12):1644-51. PubMed ID: 19822369
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, investigation and spectroscopic characterization of piroxicam ternary complexes of Fe(II), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) with glycine and DL-phenylalanine.
Mohamed GG; El-Gamel NE
Spectrochim Acta A Mol Biomol Spectrosc; 2004 Nov; 60(13):3141-54. PubMed ID: 15477157
[TBL] [Abstract][Full Text] [Related]
16. Isoxicam and related 4-hydroxy-N-isoxazolyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides. Potent nonsteroidal antiinflammatory agents.
Zinnes H; Sircar JC; Lindo N; Schwartz ML; Fabian AC; Shavel J; Kasulanis CF; Genzer JD; Lutomski C; DiPasquale G
J Med Chem; 1982 Jan; 25(1):12-8. PubMed ID: 7086815
[TBL] [Abstract][Full Text] [Related]
17. Nuclease and anti-proliferative activities of copper(II) complexes of N3O tripodal ligands involving a sterically hindered phenolate.
Berthet N; Martel-Frachet V; Michel F; Philouze C; Hamman S; Ronot X; Thomas F
Dalton Trans; 2013 Jun; 42(23):8468-83. PubMed ID: 23624882
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, spectroscopic and DFT structural characterization of two novel ruthenium(III) oxicam complexes. In vivo evaluation of anti-inflammatory and gastric damaging activities.
Tamasi G; Bernini C; Corbini G; Owens NF; Messori L; Scaletti F; Massai L; Giudice PL; Cini R
J Inorg Biochem; 2014 May; 134():25-35. PubMed ID: 24518539
[TBL] [Abstract][Full Text] [Related]
19. A mononuclear zinc(II) complex with piroxicam: crystal structure, DNA- and BSA-binding studies; in vitro cell cytotoxicity and molecular modeling of oxicam complexes.
Jannesari Z; Hadadzadeh H; Amirghofran Z; Simpson J; Khayamian T; Maleki B
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 136 Pt B():1119-33. PubMed ID: 25459509
[TBL] [Abstract][Full Text] [Related]
20. Low-temperature crystal structures of tetrakis-mu-3,5-diisopropylsalicylatobis-dimethylformamidodico pper(II) and tetrakis-mu-3,5-diisopropylsalicylatobis-diethyletheratodicopp er(II) and their role in modulating polymorphonuclear leukocyte activity in overcoming seizures.
Morgant G; Dung NH; Daran JC; Viossat B; Labouze X; Roch-Arveiller M; Greenaway FT; Cordes W; Sorenson JR
J Inorg Biochem; 2000 Jul; 81(1-2):11-22. PubMed ID: 11001426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
